Designed proteinoid polymers and nanoparticles encapsulating risperidone for enhanced antipsychotic activity
Abstract Background Nanoparticles (NPs) incorporating drug formulations can be used to facilitate passage through biological barriers including the blood–brain barrier (BBB) and increase drug delivery and bioavailability. Hence, NP-based administration may enhance the efficiency of current antipsych...
Main Authors: | L. Lugasi, I. Grinberg, S. Rudnick-Glick, E. Okun, H. Einat, S. Margel |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-10-01
|
Series: | Journal of Nanobiotechnology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12951-020-00709-z |
Similar Items
-
Proteinoid Nanocapsules as Drug Delivery System for Improving Antipsychotic Activity of Risperidone
by: Liroy Lugasi, et al.
Published: (2020-09-01) -
Engineering of Doxorubicin-Encapsulating and TRAIL-Conjugated Poly(RGD) Proteinoid Nanocapsules for Drug Delivery Applications
by: Elad Hadad, et al.
Published: (2020-12-01) -
Proteinoid Polymers and Nanocapsules for Cancer Diagnostics, Therapy and Theranostics: In Vitro and In Vivo Studies
by: Ella Itzhaki, et al.
Published: (2023-04-01) -
Tumor-Targeted Fluorescent Proteinoid Nanocapsules Encapsulating Synergistic Drugs for Personalized Cancer Therapy
by: Ella Itzhaki, et al.
Published: (2021-07-01) -
Recognition of sounds by ensembles of proteinoids
by: Panagiotis Mougkogiannis, et al.
Published: (2024-04-01)